The Clinical Application of Neoantigens in Esophageal Cancer
Esophageal cancer (EC) is a common malignant tumor with poor prognosis, and current treatments for patients with advanced EC remain unsatisfactory. Recently, immunotherapy has been recognized as a new and promising approach for various tumors. EC cells present a high tumor mutation burden and harbor...
Main Authors: | Yi-Min Gu, Yue Zhuo, Long-Qi Chen, Yong Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.703517/full |
Similar Items
-
The Role of Neoantigens in Cancer Immunotherapy
by: Yueting Zhu, et al.
Published: (2021-08-01) -
Therapeutic Vaccines Targeting Neoantigens to Induce T-Cell Immunity against Cancers
by: Shih-Cheng Pao, et al.
Published: (2022-04-01) -
Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
by: Thomas C. Wirth, et al.
Published: (2017-12-01) -
Adoptive neoantigen-reactive T cell therapy: improvement strategies and current clinical researches
by: Ruichen Huang, et al.
Published: (2023-04-01) -
The landscape of neoantigens and its clinical applications: From immunobiology to cancer vaccines
by: Chiranjib Chakraborty, et al.
Published: (2024-01-01)